About the LSX World Congress
For the last seven years, the LSX World Congress has been bringing together the executives that matter to the future of healthcare and life science strategy, investment, partnering and deal making.
LSX World Congress gathers the founders and CEOs of innovative start-ups through to publicly healthcare giants, and everyone in between.
It represents the breadth and depth of the cutting-edge research and technology driving the advances in the industry right now and in the near future.
Who is attending?
The biotech, healthtech and medtech industry’s c-suite will be joined by the sector’s most active investors, pharma and health technology business development and licensing (BD&L) teams, research and development (R&D) leaders, key opinion leaders (KOL) and top tier service companies who are driving the sector forward.
In an industry as dynamic as this, LSX World Congress brings together the people who are developing technologies, solutions and new business models to tackle the biggest healthcare challenges in the industry today, and helps answer the question; what’s next and how do we get there?
WTW is pleased to be sponsoring the LSX World Congress in 2022, helping to provide an insurance and risk management perspective.